Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer’s Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes
John A. Hey, Susan Abushakra, Aidan Power, David Watson, Anton Porsteinsson, Marwan Sabbagh, Emer MacSweeney, Sharon Cohen, Mercè Boada, P. Murali Doraiswamy, Fanny M. Elahi, Robert A. Rissman, Earvin Liang, Susan Flint, Elitza Hristova, Patrick Kesslak, Rosalind McLaine, Adem Albayrak, Jean F. Scha · 2026
Read Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer’s Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes by John A. Hey, Susan Abushakra, Aidan Power, David Watson, Anton Porsteinsson, Marwan Sabbagh, Emer MacSweeney, Sharon Cohen, Mercè Boada, P. Murali Doraiswamy, Fanny M. Elahi, Robert A. Rissman, Earvin Liang, Susan Flint, Elitza Hristova, Patrick Kesslak, Rosalind McLaine, Adem Albayrak, Jean F. Scha (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615119.txt.
Description
John Hey leads a large team in a 2026 analysis of blood marker effects of an oral drug for early Alzheimer's disease. The drug, called valiltramiprosate or ALZ-801, blocks the clumping of amyloid-beta into toxic oligomers. It is in late-stage work as a disease-modifying therapy.
The team pools data from Phase 3 and Phase 2 trials. It reads core blood markers of the disease and sets them next to clinical scores and brain scan results. One trial missed its main clinical goal overall, yet showed gains in thinking and brain volume in part of the group.
Catalog record
| CREATOR | John A. Hey, Susan Abushakra, Aidan Power, David Watson, Anton Porsteinsson, Marwan Sabbagh, Emer MacSweeney, Sharon Cohen, Mercè Boada, P. Murali Doraiswamy, Fanny M. Elahi, Robert A. Rissman, Earvin Liang, Susan Flint, Elitza Hristova, Patrick Kesslak, Rosalind McLaine, Adem Albayrak, Jean F. Scha |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |